Development and validation of a molecular classifier of meningiomas

Keyphrases

• Tumor 100%
• Hypermetabolic 100%
• Meningioma 100%
• Molecular Groups 75%
• DNA Methylation (DNAm) 50%
• Immunogenic 50%
• NF-2 50%
• Whole Exome Sequencing 25%
• Clinical Application 25%
• Deconvolution 25%
• Clinical Outcomes 25%
• Publicly Available 25%
• Macrophages 25%
• Stochasticity 25%
• Tumor Cells 25%
• Metabolic Pathway 25%
• Neoplastic Cells 25%
• Median Progression-free Survival 25%
• RNA Sequencing (RNA-seq) 25%
• Path Analysis 25%
• International Cohort 25%
• Clustering Methods 25%
• Validation Cohort 25%
• Group-specific 25%
• Omics Data 25%
• Immune Signaling 25%
• Copy number Profiling 25%
• Machine Learning Based 25%
• Clinical Heterogeneity 25%
• DNA Methylation Data 25%
• Multiple Metrics 25%
• Biological Heterogeneity 25%
• Immunogenic Tumor 25%
• NF2 Gene 25%

Immunology and Microbiology

• DNA Methylation 100%
• Macrophage 33%
• Upregulation 33%
• Cell Cycle 33%
• RNA Sequence 33%
• Multi-Omics 33%
• Progression Free Survival 33%
• Whole Exome Sequencing 33%
• Ribonucleic Acid 33%

Biochemistry, Genetics and Molecular Biology

• DNA Methylation 100%
• RNA 33%
• RNA Sequence 33%
• Cell Cycle 33%
• Macrophage 33%
• Upregulation 33%
• Progression Free Survival 33%
• Exome Sequencing 33%
• Tamsulosin 33%